Proline

Proline

SCHEMBL7546264

O=C(O)C1CCCN1.c1cc2ccc1-2

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SLC5A2

The experimentally established mechanism targets of Proline. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 3/20 0.47
SCN4A P35499 1/20 0.44
CTSC P53634 4/20 0.43
MEN1 O00255 1/20 0.42
BLM P54132 1/20 0.42
KMT2A Q03164 1/20 0.42
ELANE P08246 1/20 0.42
DPP4 P27487 1/20 0.41
DPP8 Q6V1X1 1/20 0.41
DPP9 Q86TI2 1/20 0.41
SCN3A Q9NY46 2/20 0.41
SCN9A Q15858 1/20 0.41
NOS2 P35228 2/20 0.41
NOS3 P29474 1/20 0.41
NOS1 P29475 1/20 0.41
HTR2B P41595 2/20 0.40
CTSK P43235 1/20 0.39
KCNH2 Q12809 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Biphenyl SCHEMBL2308811 0.92 ELANE (0.47) HTR2CSCN4ACTSCMEN1BLM
Proline SCHEMBL16394427 0.87 BLM (0.48) SCN4ACTSCMEN1BLMKMT2A
Proline SCHEMBL10141181 0.87
D-Proline SCHEMBL21462052 0.87 BLM (0.52) MEN1BLMKMT2ADPP4DPP8
Proline SCHEMBL2939 0.87
Proline SCHEMBL462225 0.87 BLM (0.52) MEN1BLMKMT2ADPP4DPP8
Proline SCHEMBL10141185 0.87
Proline SCHEMBL718906 0.87 BLM (0.52) MEN1BLMKMT2ADPP4DPP8
Proline SCHEMBL13248912 0.87
Proline SCHEMBL462226 0.87 BLM (0.52) MEN1BLMKMT2ADPP4DPP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024018471-A1 CATHEPSIN INHIBITORS AND USE THEREOF IN A METHOD FOR DETECTING AND TREATING RESISTANCE TO IMMUNOTHERAPY YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2024-01-25 WO disclosed
WO-2023166511-A1 IONIZABLE LIPIDS AND COMPOSITIONS COMPRISING SAME BARCODE NANOTECH LTD. (IL) 2023-09-07 WO disclosed
WO-2002055112-A2 POLYPODAL CHELANTS FOR METALLOPHARMACEUTICALS BRISTOL MYERS SQUIBB CO (US) 2002-07-18 WO disclosed